Sabinsa Corporation Receives the 2005 Thomas Alva Edison Patent Award

October 31, 2005

Sabinsa Corporation was awarded the Research & Development Council of New Jersey’s 2005 Thomas Alva Edison Patent Award in the Enabling Technology /Small Company category for its U.S. Patent #6,849,645″, method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives.”

The Thomas Alva Edison Patent Awards, which recognize the most revolutionary product innovations and important scientific breakthroughs originating in New Jersey, will be presented at the Council’s annual fall dinner on November 3, 2005, at the North Maple Inn, Basking Ridge, NJ. Sabinsa Corporation also received this award in 2004 for ForsLean® U.S. Patent #5,804,596, “Method of preparing a forskolin composition for use in promoting lean body mass and treating mood disorders.”

“We strive to provide the most innovative, functional ingredients that are supported by extensive scientific research, and this award is a wonderful recognition of our efforts in this arena,” stated Dr. Muhammed Majeed, founder and CEO, Sabinsa Corporation.

View Newsletter (PDF)